-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $24.50 at Jefferies, 'execution story now'
-
-
-
-
-
-
-
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
-
-
-
-
-
-
-
Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 3c, Offers Guidance
-
-
-
-
-
-
-
Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill
-
-
-
-
-
-
-
Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'
-
-
-
-
-
-
-
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy(R) Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman
-
-
-
-
-
-
-
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
-
1,222,424 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

